Merck & Co., Inc.
MRK · NYSE · Healthcare
145.66USD−1.71▼ −1.16%
Prices delayed 15 minutes
Key data
- Market cap
- 359.37B USD
- P/E ratio
- 20.01
- EPS (trailing 12 months)
- 7.28 USD
- Revenue (trailing 12 months)
- 65.01B USD
- Dividend yield
- 2.33%
- Price-to-book
- 8.57
- Beta (volatility)
- 0.14
- Average volume (20 sessions)
- 9.59M
52-week low and high
82.01156.92
Latest news & analysis
Company filingsMerck Appoints Paul Diaz to Board of Directors Effective NovemberMerck announced that Paul Diaz will join its board of directors effective November 1, 2026, bringing the board to 14 members.Company filingsMerck: Change in Executive Management or Board of DirectorsMerck (MRK) disclosed to the US Securities and Exchange Commission (SEC): a change in executive management or board of directors.
For information only; not a recommendation to buy or sell. Prices may be delayed up to 15 minutes.